SIMILAR RISK OF HEPATOCELLULAR CARCINOMA (HCC) DEVELOPMENT DURING LONG-TERM ENTECAVIR (ETV) OR TENOFOVIR DISOPROXIL FUMARATE (TDF) THERAPY IN CAUCASIAN CHRONIC HEPATITIS B (CHB) PATIENTS

被引:0
|
作者
Papatheodoridis, George V. [1 ]
Dalekos, George N. [2 ,3 ]
Yurdaydin, Cihan [4 ]
Sypsa, Vana [5 ]
van Boemmel, Florian [6 ]
Buti, Maria [7 ,8 ]
Luis Calleja, Jose [9 ]
Goulis, Ioannis [10 ]
Manolakopoulos, Spilios [1 ,11 ]
Loglio, Alessandro [12 ]
Papatheodoridi, Margarita [1 ]
Gatselis, Nikolaos K. [2 ,3 ]
Keskin, Onur [4 ]
Veelken, Rhea [6 ]
Lopez Gomez, Marta [13 ]
Hansen, Bettina E. [14 ,15 ]
Savvidou, Savvoula [10 ]
Kourikou, Anastasia [11 ]
Vlachogiannakos, Jiannis [1 ]
Galanis, Kostas [2 ,3 ]
Idilman, Ramazan [4 ]
Esteban-Mur, Rafael [7 ,8 ]
Janssen, Harry L. A. [16 ]
Berg, Thomas [17 ]
Lampertico, Pietro [12 ]
机构
[1] Univ Athens, Gen Hosp Athens Laiko, Sch Med, Dept Gastroenterol, Athens, Greece
[2] Thessalia Univ, Sch Med, Dept Internal Med, Volos, Greece
[3] Thessalia Univ, Sch Med, Res Lab, Volos, Greece
[4] Ankara Univ, Sch Med, Dept Gastroenterol, Ankara, Turkey
[5] Univ Athens, Sch Med, Dept Hyg Epidemiol & Med Stat, Athens, Greece
[6] Univ Clin Leipzig, Clin Gastroenterol & Rheumatol, Sect Hepatol, Leipzig, Germany
[7] Hosp Gen Univ Valle Hebron, Barcelona, Spain
[8] Ciberehd, Barcelona, Spain
[9] Univ Autonoma Madrid, Hosp Univ Puerta De Hierro Majadahonda, Liver Unit, Madrid, Spain
[10] Aristotle Univ Thessaloniki, Sch Med, Hippocrat Univ Hosp, Dept Internal Med 4, Thessaloniki, Greece
[11] Univ Athens, Gen Hosp Athens Hippokratio, Sch Med, Dept Internal Med 2, Athens, Greece
[12] Univ Milan, Fdn Irccs Ca Granda Osped Maggiore Policlin, Div Gastroenterol & Hepatol, CRC AM&A Migliavacca Ctr Liver Dis, Milan, Italy
[13] Hosp Univ Puerta De Hierro, Idiphim, Ciberehd, Madrid, Spain
[14] Univ Hlth Network, Toronto Western & Gen Hosp, Liver Clin, Toronto, ON, Canada
[15] Erasmus MC, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands
[16] Univ Hlth Network, Toronto Ctr Liver Dis, Toronto, ON, Canada
[17] Univ Hosp Leipzig, Sect Hepatol, Dept Gastroenterol & Rheumatol, Leipzig, Germany
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
454
引用
收藏
页码:286A / 287A
页数:2
相关论文
共 50 条
  • [1] ALT Levels and Risk of Hepatocellular Carcinoma (HCC) in Caucasian Chronic Hepatitis B (CHB) Patients Under Long-Term Therapy with Entecavir (ETV) or Tenofovir Disoproxil Fumarate (TDF)
    Papatheodoridis, George V.
    Dalekos, George N.
    Yurdaydin, Cihan
    Sypsa, Vana
    van Bommel, Florian
    Buti, Maria
    Luis Calleja, Jose
    Chi, Heng
    Goulis, Ioannis
    Manolakopoulos, Spilios
    Loglio, Alessandro
    Siakavellas, Spyros
    Keskin, Onur
    Veelken, Rhea
    Lopez-Gomez, Marta
    Hansen, Bettina E.
    Savvidou, Savvoula
    Kourikou, Anastasia
    Vlachogiannakos, Ioannis
    Galanis, Kostas
    Idilman, Ramazan
    Esteban, Rafael
    Janssen, Harry L. A.
    Berg, Thomas
    Lampertico, Pietro
    [J]. HEPATOLOGY, 2018, 68 : 162A - 163A
  • [2] Outcomes and characteristics of hepatocellular carcinomas (HCC) in Caucasian chronic hepatitis B (CHB) patients treated with long-term entecavir (ETV) or tenofovir disoproxil fumarate (TDF) therapy
    Papatheodoridis, George
    Dalekos, George
    Idilman, Ramazan
    Sypsa, Vana
    Buti, Maria
    Calleja Panero, Jose Luis
    Goulis, Ioannis
    Sonneveld, Milan
    van Bommel, Florian
    Manolakopoulos, Spilios
    Loglio, Alessandro
    Papatheodoridi, Margarita
    Gatselis, Nikolaos
    Lopez-Gomez, Marta
    Savvidou, Savvoula
    Brakenhoff, Sylvia
    Samakidou, Anna
    Yurdaydin, Cihan
    Esteban, Rafael
    Janssen, Harry
    Berg, Thomas
    Lampertico, Pietro
    [J]. JOURNAL OF HEPATOLOGY, 2021, 75 : S747 - S748
  • [3] PAGE-B: RISK SCORE FOR HEPATOCELLULAR CARCINOMA (HCC) DEVELOPMENT IN CAUCASIAN CHRONIC HEPATITIS B (CHB) PATIENTS RECEIVING ENTECAVIR (ETV) OR TENOFOVIR (TDF)
    Papatheodoridis, G. V.
    Dalekos, G.
    Sypsa, V.
    Yurdaydin, C.
    Buti, M.
    Goulis, J.
    Arends, P.
    Manolakopoulos, S.
    Mangia, G.
    Gatselis, N.
    Keskin, O.
    Savvidou, S.
    Hansen, B. E.
    Papaioannou, C.
    Galanis, K.
    Idilman, R.
    Colombo, M.
    Esteban, R.
    Janssen, H. L. A.
    Lampertico, P.
    [J]. JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S435 - S435
  • [4] Decreasing risk of hepatocellular carcinoma (HCC) development after the first 5 years of entecavir (ETV) or tenofovir (TDF) therapy in Caucasian chronic hepatitis B (CHB) patients
    Papatheodoridis, George V.
    Idilman, Ramazan
    Dalekos, George N.
    Buti, Maria
    Chi, Heng
    van Boemmel, Florian
    Luis Calleja, Jose
    Sypsa, Vana
    Goulis, Ioannis
    Manolakopoulos, Spilios
    Invernizzi, Federica
    Siakavellas, Spyros I.
    Keskin, Onur
    Gatselis, Nikolaos
    Hansen, Bettina E.
    Lehretz, Maria
    de la Revilla, Juan
    Savvidou, Savvoula
    Kourikou, Anastasia
    Facchetti, Floriana
    Vlachogiannakos, Jiannis
    Galanis, Kostas
    Yurdaydin, Cihan
    Berg, Thomas
    Colombo, Massimo
    Esteban, Rafael
    Janssen, Harry L.
    Lampertico, Pietro
    [J]. HEPATOLOGY, 2015, 62 : 1188A - 1189A
  • [5] Risk and risk factors of hepatocellular carcinoma (HCC) in Caucasian chronic hepatitis B (CHB) patients with or without cirrhosis treated with entecavir (ETV) or tenofovir (TDF)
    Papatheodoridis, George V.
    Dalekos, George N.
    Yurdaydin, Cihan
    Goulis, Ioannis
    Arends, Pauline
    Buti, Maria
    Sypsa, Vana
    Manolakopoulos, Spilios
    Mangia, Giampaolo
    Gatselis, Nikolaos
    Keskin, Onur
    Savvidou, Savvoula
    Hansen, Bettina E.
    Papaioannou, Christos
    Galanis, Kostas
    Idilman, Ramazan
    Colombo, Massimo
    Esteban, Rafael
    Janssen, Harry L.
    Lampertico, Pietro
    [J]. HEPATOLOGY, 2013, 58 : 302A - 303A
  • [6] The risk of hepatocellular carcinoma (HCC) is decreasing after the first 5 years of entecavir (ETV) or tenofovir (TDF) therapy in Caucasian chronic hepatitis B (CHB) patients
    Papatheodoridis, George V.
    Yurdaydin, Cihan
    Dalekos, George N.
    Buti, Maria
    Chi, Heng
    van Boemmel, Florian
    Calleja, Jose L.
    Sypsa, Vana
    Goulis, Ioannis
    Manolakopoulos, Spilios
    Loglio, Alessandro
    Siakavellas, Spyros I.
    Keskin, Onur
    Gatselis, Nikolaos
    Hansen, Bettina E.
    Lehretz, Maria
    de la Revilla, Juan
    Savvidou, Savvoula
    Kourikou, Anastasia
    Vlachogiannakos, Jiannis
    Idilman, Ramazan
    Galanis, Kostas
    Berg, Thomas
    Colombo, Massimo
    Esteban, Rafael
    Janssen, Harry L.
    Lampertico, Pietro
    [J]. HEPATOLOGY, 2016, 64 : 923A - 923A
  • [7] Similar risk of hepatocellular carcinoma during long-term entecavir or tenofovir therapy in Caucasian patients with chronic hepatitis B
    Papatheodoridis, George, V
    Dalekos, George N.
    Idilman, Ramazan
    Sypsa, Vana
    Van Boemmel, Florian
    Buti, Maria
    Calleja, Jose Luis
    Goulis, John
    Manolakopoulos, Spilios
    Loglio, Alessandro
    Papatheodoridi, Margarita
    Gatselis, Nikolaos
    Veelken, Rhea
    Lopez-Gomez, Marta
    Hansen, Bettina E.
    Savvidou, Savvoula
    Kourikou, Anastasia
    Vlachogiannakos, John
    Galanis, Kostas
    Yurdaydin, Cihan
    Esteban, Rafael
    Janssen, Harry L. A.
    Berg, Thomas
    Lampertico, Pietro
    [J]. JOURNAL OF HEPATOLOGY, 2020, 73 (05) : 1037 - 1045
  • [8] Similar risk of hepatocellular carcinoma during long-term entecavir or tenofovir therapy in Caucasian patients with chronic hepatitis B
    Wen, Zhili
    Feng, Yuliang
    Yan, Xiaohua
    [J]. JOURNAL OF HEPATOLOGY, 2021, 74 (01) : 245 - 246
  • [9] Prediction and Need for Surveillance of Hepatocellular Carcinoma (HCC) Development after the First 5 Years of Entecavir (ETV) or Tenofovir Disoproxil Fumarate (TDF) Therapy in Caucasian Chronic Hepatitis B (CHB) Patients of the PAGE-B Cohort
    Papatheodoridis, George V.
    Dalekos, George N.
    Yurdaydin, Cihan
    Sypsa, Vana
    van Bommel, Florian
    Buti, Maria
    Calleja, Jose Luis
    Chi, Heng
    Goulis, Ioannis
    Manolakopoulos, Spilios
    Loglio, Alessandro
    Siakavellas, Spyros
    Gatselis, Nikolaos K.
    Keskin, Onur
    Veelken, Rhea
    Lopez-Gomez, Marta
    Hansen, Bettina E.
    Savvidou, Savvoula
    Kourikou, Anastasia
    Vlachogiannakos, Ioannis
    Galanis, Kostas
    Idilman, Ramazan
    Esteban, Rafael
    Janssen, Harry L. A.
    Berg, Thomas
    Lampertico, Pietro
    [J]. HEPATOLOGY, 2018, 68 : 11A - 12A
  • [10] Hepatocellular carcinoma (HCC) is the only factor affecting the excellent survival of Caucasian chronic hepatitis B (CHB) patients with or without cirrhosis under long-term entecavir (ETV) or tenofovir (TDF) therapy
    Papatheodoridis, George V.
    Dalekos, George N.
    Yurdaydin, Cihan
    van Boemmel, Florian
    Buti, Maria
    Sypsa, Vana
    Goulis, John
    Calleja, Jose L.
    Chi, Heng
    Manolakopoulos, Spilios
    Loglio, Alessandro
    Gatselis, Nikolaos
    Keskin, Onur
    Lehretz, Maria
    Savvidou, Savvoula
    de la Revilla, Juan
    Hansen, Bettina E.
    Vlachogiannakos, Jiannis
    Galanis, Kostas
    Idilman, Ramazan
    Colombo, Massimo
    Esteban, Rafael
    Janssen, Harry L.
    Berg, Thomas
    Lampertico, Pietro
    [J]. HEPATOLOGY, 2016, 64 : 35A - 36A